There was no correlation between IRF-2 expression and clinical characteristics including age, sex, tumor size, invasive depth, lymph node metastasis, tumor position, and TNM stage (P > 0.05). The gene discussed is IRF2; the disease is metastatic malignant neoplasm in the lymph nodes.